VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 52 filers reported holding VERRICA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 300 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | +50.0% | 300 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | -88.9% | 300 | -82.4% | 0.00% | – |
| Q2 2020 | $18,000 | 0.0% | 1,700 | 0.0% | 0.00% | – |
| Q1 2020 | $18,000 | -33.3% | 1,700 | 0.0% | 0.00% | – |
| Q4 2019 | $27,000 | -46.0% | 1,700 | -50.0% | 0.00% | – |
| Q3 2019 | $50,000 | +163.2% | 3,400 | +100.0% | 0.00% | – |
| Q2 2019 | $19,000 | +5.6% | 1,700 | 0.0% | 0.00% | – |
| Q1 2019 | $18,000 | +38.5% | 1,700 | 0.0% | 0.00% | – |
| Q4 2018 | $13,000 | -51.9% | 1,700 | 0.0% | 0.00% | – |
| Q3 2018 | $27,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,410,412 | $55,419,000 | 1.48% |
| Asymmetry Capital Management, L.P. | 76,885 | $1,249,000 | 1.15% |
| Fosun International Ltd | 794,279 | $12,907,000 | 0.62% |
| Orbimed Advisors | 1,479,733 | $24,046,000 | 0.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 117,000 | $1,901,000 | 0.22% |
| Capital Investment Advisory Services, LLC | 10,700 | $174,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 20,000 | $325,000 | 0.07% |
| CONNING INC. | 129,013 | $2,096,000 | 0.06% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 215,145 | $3,496,000 | 0.06% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 34,812 | $566,000 | 0.03% |